Considerations of safety for women prescribed apixaban or rivaroxaban who breastfeed-a physiologically based pharmacokinetic analysis.

BACKGROUND: The risk of venous thromboembolism is significantly increased during the perinatal period. The safety of the direct oral anticoagulants, apixaban and rivaroxaban, has not been established in women who breastfeed. Physiologically based pha…

Preview only. Read the full abstract at the source